Physician

Voltaire Velarde, MD

According to 2025 Medicare claims, Voltaire Velarde, MD (NPI: 1538243340) practices internal medicine in the Vallejo, CA market, with the plurality of this provider's patient population coming from Solano, CA. This provider's primary affiliated billing organization is VOLTAIRE S VELARDE MD INC (NPI: 1528180205; TIN: 680413217) and primary practice location at 94589-2567. Velarde is affiliated with the Aledade 60 CA MSSP Enhanced (ACO ID: A4775), participating under the MSSP model.

Velarde's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 410 traditional Medicare patients, billed 3,311 HCPCS/CPT codes, and received $252,477 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,731 prescription claims across 479 beneficiaries totaling $902,021 in drug costs, led by Jardiance (Empagliflozin). DME data shows 260 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $649,948 to $902,021. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,312 and ending at $13,520.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	566	2,826	$185,187
2016	577	4,119	$280,331
2017	936	5,169	$230,776
2018	514	4,476	$280,222
2019	541	4,750	$323,247
2020	629	4,276	$252,129
2021	637	3,773	$257,992
2022	630	3,215	$226,940
2023	538	3,188	$245,579
2024	410	3,311	$252,477

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	464	9,582	$649,948
2016	429	8,120	$562,843
2017	537	8,434	$602,239
2018	457	7,229	$551,334
2019	406	7,162	$577,212
2020	473	7,606	$624,638
2021	469	8,221	$823,379
2022	444	7,045	$855,116
2023	410	6,944	$1,068,028
2024	479	6,731	$902,021

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	149	483	$13,874
2016	180	557	$14,875
2017	123	476	$8,818
2018	144	551	$8,705
2019	167	521	$11,594
2020	112	454	$8,005
2021	138	519	$14,065
2022	97	402	$9,818
2023	53	260	$6,682
2024	61	260	$11,265

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	278	278	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	296	773	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	237	420	$74
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	236	655	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	255	583	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	140	11,970	$213,468
Farxiga	Dapagliflozin Propanediol	83	5,278	$89,476
Eliquis	Apixaban	70	4,474	$86,155
Rybelsus	Semaglutide	37	2,490	$76,155
Ozempic	Semaglutide	26	1,302	$41,119

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	22	$6,154
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	45	$1,992
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	34	73	$1,153
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$841
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	18	$466

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Voltaire Velarde, MD?

Tedicare shows public-source Medicare data for Voltaire Velarde, MD (NPI 1538243340), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Voltaire Velarde, MD have ACO affiliation data?

Voltaire Velarde, MD is shown with ACO affiliation data for Aledade 60 CA MSSP Enhanced (MSSP, ACO ID A4775).

What billing organization is linked to Voltaire Velarde, MD?

Voltaire Velarde, MD is linked to VOLTAIRE S VELARDE MD INC (billing NPI 1528180205) in the available physician profile data.

Does Voltaire Velarde, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.